SEC Form 4 · accession 0001104659-16-161732
Aralez Pharmaceuticals Inc. · ARLZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Seth Rudnick
Director
Period of report
Nov 23, 2016
Accepted (ET)
Dec 12, 2016 · 8:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660719
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par value | Nov 23, 2016 | G | 30,000 | $0.00 | D | 64,391 | D | |
| Common Shares, without par valueF1 | Nov 23, 2016 | G | 30,000 | $0.00 | A | 30,000 | I | By trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are held in the Seth A. Rudnick 2014 GST Trust U/A Dated 03/01/2014 (the "Trust") for the benefit of the Reporting Person's heirs. The Reporting Person's spouse is trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.